Ildong Pharmaceutical Appoints Jaehong Park as New President and Head of R&D
Former Chief Scientific Officer at Dong-A ST
Ildong Pharmaceutical announced on April 1 that it has recruited Dr. Jaehong Park and appointed him as the new President and Head of Research and Development (R&D).
Jaehong Park, President and Head of R&D at Ildong Pharmaceutical. Ildong Pharmaceutical
View original imageBorn in 1969, President Park obtained his bachelor's and master's degrees in biotechnology from Yonsei University, and earned his Ph.D. from Boston University School of Medicine in the United States. He subsequently worked as a researcher at institutions including Harvard Medical School.
He then accumulated diverse experience in new drug clinical development and commercialization at global pharmaceutical companies such as Janssen, Takeda Pharmaceutical, and Boehringer Ingelheim. In 2022, he joined Dong-A ST as Chief Scientific Officer (CSO), leading the company's R&D operations.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Going forward, President Park will oversee all R&D activities at Ildong Pharmaceutical, including new drug research and development.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.